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The microorganisms in the human gastrointestinal tract have a profound inﬂuence on the
transformation of food intometaboliteswhich can impact human health. Gallic acid (GA) and
pyrogallol (PG) are bioactive compounds displaying diverse biological properties, including
carcinogenic inhibiting activities. However, its concentration in fruits and vegetables
is generally low. These metabolites can be also generated as ﬁnal products of tannin
metabolism by microbes endowed with tannase, which opens up the possibility of their
anti-cancer potential being increased. Patients with colorectal cancer (CRC) display an
imbalanced gut microbiota respect to healthy population.The recent use of next generation
sequencing technologies has greatly improved knowledge of the identity of bacterial
species that colonize non-tumorous and tumorous tissues of CRC patients.This information
provides a unique opportunity to shed light on the role played by gut microorganisms in
the different stages of this disease.We here review the recently published gut microbiome
associated to CRC patients and highlight tannase as an underlying gene function of bacterial
species that selectively colonize tumorous tissues, but not adjacent non-malignant tissues.
Given the anti-carcinogenic roles of GA and PG produced by gut tannin-degrading bacteria,
we provide an overview of the possible consequences of this intriguing coincidence for
CRC development.
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INTRODUCTION
An imbalance in intestinal bacteria potentially leading to diseases
termed colonic dysbiosis is associated to CRC, however, the possi-
ble role of intestinal microorganisms in the different CRC-stages
is currently under debate.
Host diet is a crucial variable to shape the gut microbiota and
a risk factor for CRC. Increased fruit and vegetable consumption
is a dietary habit modiﬁcation aimed to prevent gastrointestinal
cancer (WHO Technical Report Series, No. 916 [TRS 916], 2003).
Plant foods are main sources of tannins, dietary phytonutrients
that display pro-apoptotic and antimetastasic properties in animal
and in vitro studies (Serrano et al., 2009). Despite its promising
chemopreventive potential, results from human studies to eval-
uate the association between the intake of foods rich in tannins
and cancer risk are more dissuading. For example, inverse associa-
tion (Theodoratou et al., 2007) but also no association (Kyle et al.,
2010) between dietary proanthocyanidin intake andCRC risk have
been reported. These apparently conﬂicting results may reﬂect
interindividual differences in gut microbiota and reveal the difﬁ-
culty to infer biological effects from dietary intake records without
considering tannin-microbiota interactions. The microorganisms
in the human gastrointestinal tract have a profound inﬂuence on
the transformation of food into metabolites which can impact
human health (Nicholson et al., 2012). Thus, the highly individ-
ual gut microbial activity, in particular the tannin-metabolizing
Abbreviations: CRC, colorectal cancer; GA, gallic acid; PG,pyrogallol; ROS, reactive
oxygen species.
activity of CRC-associated microbiota, will probably determine
the bioavailability and physiological effects of tannins and their
degradation products on tumorous tissues.
TANNASE: A COMMON FUNCTION IN THE MICROBIOTA
COLONIZING COLORECTAL TUMOROUS TISSUES
Gut microbial tannase activity is likely crucial to determine the
tannin-metabolizing phenotype of CRC-associated microbiota.
Tannase (tannin acylhydrolase) transforms the gallate esters of
tannins and other phenolic compounds, such as epigallocate-
chin gallate, into GA. GA can, subsequently, be decarboxylated
by gallate decarboxylase to yield PG as ﬁnal product of tannin
metabolism. The capacity for tannin degradation is a survival
advantage over other gut microorganisms because tannins dis-
play antimicrobial activity (Chung et al., 1998), reduce the species
richness in the gut (Tan et al., 2013) and probably improve
the adaptation of tannin-degrading bacteria to the intestinal
environment (Reverón et al., 2013).
Recently the CRC microbiome encompassing all DNA within
the microbiota of late stage CRC patients has been disclosed
(Tjalsma et al., 2012). This information enabled these authors
to ﬂesh out the microbiota that colonizes tumorous or adjacent
non-malignant sites. If one focuses on these intestinal microor-
ganisms and perform a search for homologous genes to the
known Lactobacillus plantarum tannase gene (KEGG database
http://www.genome.jp/kegg/), only bacterial spp. speciﬁcally
overrepresented in tumorous tissues, but not in adjacent non-
malignant tissues, display tannase-homologous genes (Table 1).
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Table 1 | Gut microbial tannase in late stage CRC-patients.
On tumora Organism Tannase Geneb
Roseburia R. intestinalis XB6B4 + rix:RO1_26850
Streptococcaceae Streptococcus gallolyticus ATCC 3143 + sgt:SGGB_1624
S. gallolyticus ATCC BAA-2069 + sgg:SGGBAA2069_c16370
S. gallolyticus UCN34 + sga:GALLO_1609
S. gallolyticus UCN34 + sga:GALLO_0933
S. gallolyticus ATCC 3143 + sgt:SGGB_0917
S. gallolyticus ATCC BAA-2069 + sgg:SGGBAA2069_c09070
S. gallolyticus ATCC BAA-2069 + sgg:SGGBAA2069_c09080
Fusobacterium F. nucleatum subsp. vincentii + fnc:HMPREF0946_00654
F. nucleatum subsp. nucleatum ATCC 25586 + fnu:FN0616
F. nucleatum subsp. animalis + fus:HMPREF0409_00517
Aggregatibacter A. actinomycetemcomitans D7S-1 + aan:D7S_02361
A. actinomycetemcomitans D11S-1 + aat:D11S_1302
A. aphrophilus + aap:NT05HA_0741
A. actinomycetemcomitans ANH9381 + aao:ANH9381_1645
Coriobacteriaceae Slackia heliotrinireducens + shi:Shel_22280
Collinsella NA
Coriobacterium glomerans −
Peptostreptococcaceae NA
Off tumora
Enterobacteriaceae Citrobacter −
Shigella −
Cronobacter −
Kluyveria NA
Serratia −
Salmonella −
Ruminococcus −
Clostridiumc +
Anaerovorax NA
Eubacterium −
On/Off tumora
Bacteroides −
Faecalibacterium −
aOn tumor: bacteria inhabiting tumorous tissues; Off tumor: bacteria inhabiting adjacent healthy tissues; On/Off tumor: bacteria inhabiting indistinctly tumorous and
adjacent healthy tissues.
bHomologous genes to L. plantarum tannase lp_2956.
cTwo Clostridium spp. (C. botulinum E3 and C. strain SY8519) displayed genes with homology to L. plantarum tannase. However, this spp. are not reportedly associated
to colorectal malignancies.
NA. Sequence not available.
This intriguing coincidence could be consistent with the selec-
tivity of plant phenolic compounds to target cancer cells (Azmi
et al., 2013) and suggest that the presence of gut microbial tannase
activity may have potential implications on the colonic epithelial
health.
IMPORTANCE OF TANNASE-GENERATED METABOLITES IN
CRC DEVELOPMENT
Recent ﬁndings have highlighted the potent DNA-damaging
activities of tannins and tannase-derived metabolites, including
PG, GA, and epigallocatechin gallate (Hossain et al., 2013). The
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genotoxic behavior of these metabolites is determined by its pro-
oxidant activity which is in line with the pro-oxidant activity
displayed by a number of further anti-cancer phenolic compounds
in cellular/biological systems (Azmi et al., 2013).
Although the antioxidant capacity of tannins, PG and GA, is
generally accepted, its pro-oxidant behavior should not be surpris-
ing. Thus, plants elaborate these natural phenolics to have, among
other important functions, antimicrobial activity and antimicro-
bials share a common mechanism to kill bacteria: through the
overproduction of ROS (Kohanski et al., 2007).
It is to be noted that the pro-oxidant behavior of tannase-
derived metabolites in CRC-tissues can be boosted in the colon
compared to the small intestine due to a more pronounced
pro-oxidant environment in the former (Sanders et al., 2004).
The presence of cooper, a transition metal participating in
the Fenton-like chemistry, is another factor for inducing the
chemopreventive, pro-oxidant behavior of certain plant pheno-
lic compounds (Azmi et al., 2013), including GA (Hossain et al.,
2013), especially when it has been found in particularly aug-
mented concentrations in a number of malignancies (Linder,
2012). Nevertheless some phenolics, such as PG,do not necessarily
require a metal ion catalyst to produce OH radicals (Hossain et al.,
2013).
Given the pro-oxidant activity of plant phenolics has been pro-
posed as one of its anti-cancer properties (Azmi et al., 2013), the
question arises as to whether the production of GA and PG by
tannase-producing CRC-associated bacteria affects CRC develop-
ment. There are several hints that the answer is yes. ThepotentROS
generation by GA and particularly PG strongly activates the tumor
suppressor p53 in RKO CRC cells (Hossain et al., 2013). In addi-
tion GA and PG are known glutathione depletors (Park et al., 2007;
You and Park, 2010) and could directly exert a cancer cell killing
action via potent ROS generation. Hence, the selective produc-
tion of GA/PG by the CRC-associated microbiota could promote
pro-oxidative stress in the tumorous tissues to increase the direct
or apoptotic killing (via p53 activation) of cancerous cells. Con-
sistent with this hypothesis recent ﬁndings have suggested that
tannase-mediated biotransformation of green tea extracts or epi-
gallocatechin gallate in vitro modulates the expression of several
pro and anti-apoptotic genes to enhance the pro-apoptotic behav-
ior of these natural compounds (Macedo et al., 2012). Although
details on these regulatory effects were not reported, an increased
bioavailability of GA produced by tannase could account for the
observed differences. Besides inﬂuencing apoptotic processes, GA
modulates the expression of genes involved in cell cycle, angio-
genesis, and metastasis inducing death in various cancer cell lines
(Verma et al., 2013). Among other processesGA signiﬁcantlymod-
ulates NF-κB, Akt, and ATM kinase signaling pathways to prevent
the processes of carcinogenesis and it is a competitive inhibitor of
the pro-inﬂammatory mediator COX-2.
ENHANCING THE ANTI-CARCINOGENIC POTENTIAL OF
GALLIC ACID AND PYROGALLOL BY THE GUT
TANNIN-DEGRADING BACTERIA COLONIZING COLORECTAL
TUMOROUS TISSUES
Gallic acid and PG display anticancer properties, however, it
must be noted that its concentration in fruits and vegetables is
generally low (Tomas-Barberán and Clifford, 2000). Hence the
tannic acid transformation performance by gut tannin-degrading
bacteria will likely play a key role to increase the concentration
and bioactivity of GA and PG in the colon. The bioaccumu-
lation of GA and PG in microbial bioﬁlms may be another
factor contributing to increase the anti-carcinogenic effects of
these bioactive compounds. In this respect, bioﬁlm formation
on the collagen-rich surfaces accessible in the displaced mucosal
epithelium of carcinomas is the most outstanding characteris-
tic of Streptococcus gallolyticus, a tannin-degrading bacterium
unquestionably associated to CRC (Tjalsma et al., 2012). This
bacterium has been proposed to increase, via adhesion, col-
onization of tumorous tissues by members of Fusobacterium
spp. [another bacterium with capacity to produce tannase
(Table 1)] which in turn own capacity to adhere to other
bacterial ssp. and attract them to the tumor (Tjalsma et al.,
2012). According to this colonization pattern and given bac-
terial taxa of the microbiome colonizing colon tumor tissues
generally own the capacity to produce tannase (Table 1), it
is conceivable to speculate on the formation of multispecies
bioﬁlms on cancerous tissues settled by bacteria able to pro-
cess dietary tannins. Microbe-generated GA and PG accumulated
in these bioﬁlms may thus selectively increase its bioavailabil-
ity and bioactivity in the tumorous tissues. While this scenario
is probably correct for tumorous tissues of late stage CRC
patients, it is doubtful to anticipate the same in early and
adenomatous stages as the occurrence of tannase-producing
opportunistic pathogens in the healthy human gut, such as S.
gallolyticus or Fusobacterium spp., is very rare (Tjalsma et al.,
2012). In this regard, unraveling the microbiomes associated
to the early and adenomatous stages of CRC will be crucial
to deﬁne the speciﬁc role of tannase-producing bacteria in
CRC development. In addition, the identiﬁcation of the gut
microbiota in CRC patients in epidemiological studies address-
ing the association between dietary tannin intake records and
tumor recurrence or regression, may be critical in understand-
ing the role of gut bacteria on the anti-cancer effects of dietary
polyphenols.
CONCLUSION
Tannase is anunderlying gene functionof gutmicroorganisms that
selectively colonize tumorous tissues of late stage CRC patients.
Based on the anti-carcinogenic inducing roles reported for GA
and PG, the observed colonization pattern suggests that these gut
tannin-degrading bacteria are involved in the prevention rather
than promotion of tumor progression. Tannase then could be
submitted as a link in the yet elusive relationship between dietary
factors, CRC-associated gut microbiota and CRC progression. A
drawback to this hypothesis is that the ROS-mediated anti-cancer
effects of the GA and PG produced by the tannase-producing bac-
teria naturally colonizing tumorous tissues could be blocked by
the high levels of ROS-destroying antioxidants usually possessed
by the cancerous cells. Nevertheless, therapeutic microbiology
strategies considering the afﬁnity of tannase-producing bacteria
for colonic tumorous tissues could be a powerful weapon to efﬁ-
ciently produce ROS-generating drugs that selectively kill CRC
cells.
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